Nigeria files new Pfizer claims

Nigeria has accused Pfizer of fraud in a fresh court case filed against the drugs firm over its alleged role in the deaths of Nigerian children.

The government earlier withdrew the case – just as it was due to begin in the capital Abuja – to add new charges.

The government is seeking $7bn (£3

Watchdog probes drug distribution

The UK’s Office of Fair Trading (OFT) has begun a probe into the UK supply of medicines, after changes at the world’s biggest pharmaceutical firm, Pfizer.

Earlier this month, Pfizer began selling its prescription drugs through just one medical wholesaler, Unichem.

This was designed to tackle the rise in fake medicines, but patient groups said it could limit access to vital drugs

Group sues Pfizer, other drug makers over imports

A Minnesota seniors group sued nine major pharmaceutical manufacturers on Wednesday, alleging that the companies have conspired to keep U.S. medicine prices artificially high by blocking Canadian imports

Pfizer claims Britons denied treatment

LONDON, Jan 7 (Reuters) – Britons suffering from Alzheimer’s disease are being denied drugs that can delay disease progression, according to a study by drugmaker Pfizer Inc (nyse: PFE – news – people) showing significant regional variations in spending.

The company, which co-markets Alzheimer’s treatment Aricept with Japan’s Eisai Co Ltd <4523.T>, said that although overall spending on anti-dementia drugs had increased significantly in the UK, some health authority areas spent four times as much as others

Pfizer to use DART for online campaigns

NEW YORK, Jan. 8 /PRNewswire-FirstCall/ — DoubleClick Inc. (Nasdaq: DCLK),

the leading provider of tools for advertisers, web publishers and direct

marketers today announced that Carat Interactive, a leading global media

agency, has agreed to exclusively use DoubleClick’s ad management system,

DART(R) for Advertisers, on behalf of Pfizer Inc in order to deliver, report

on and measure its online marketing and advertising campaigns

State Tax Report

In a decision that reinforces the state’s right to tax companies on all transactions, Chancellor Carol McCoy ruled against Pfizer, Inc., in its lawsuit against Tennessee Commissioner of Revenue Loren Chumley.

“Pfizer has misconstrued the statutory classifications,” McCoy said in her judgment